Yield10 Bioscience files request for regulatory status review with USDA-APHIS

Yield10 Bioscience announced that the Company recently filed a request for a Regulatory Status Review with USDA-APHIS Biotechnology Regulatory Services under the Sustainable, Ecological, Consistent, Uniform, Responsible, Efficient Rule for proprietary elite Camelina sativa varieties designed to produce seed oil containing both essential omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid. The genetic pathway deployed in the omega-3 Camelina DHA1 line described in the Company’s RSR submission produces oil containing approximately 10% EPA and 10% DHA, closely resembling the omega-3 EPA/DHA fatty acid profile of northern hemisphere fish oil. Yield10 is making plans to conduct field work with omega-3 Camelina with the goal to begin the ramp-up of seed inventory for future planting as well as to produce omega-3 oil for use in business development activities. “Based on the scientific work published by the Rothamsted Institute, including salmon feeding and human clinical trials, we believe the Camelina omega-3 technology represents an ideal platform for the sustainable, land-based production of high value, omega-3 oils to address the significant potential opportunity in the global aquafeed and human nutrition markets,” said Kristi Snell, Ph.D., Chief Science Officer of Yield10 Bioscience. “We believe Camelina-based production of omega-3 oil containing EPA and DHA is a promising solution to address the ongoing shortfalls in supply of omega-3 oil from fish oil and sustainably meet the projected increase in global demand for omega-3 oil in the years to come. We are focused on advancing our omega-3 oil producing Camelina along the regulatory path, building seed inventory and engaging with potential commercial partners.”